FiercePharma: Grifols to Acquire Talecris Biotherapeutics Creating a World Leading Provider of Life-Saving Plasma Protein Therapies
- The combination of Grifols and Talecris will create a diversified, global provider of life-saving and life enhancing plasma protein therapeutics built on the strong global presence of Grifols and ...
Grifols to Acquire Talecris Biotherapeutics Creating a World Leading Provider of Life-Saving Plasma Protein Therapies
Grifols is a global healthcare company that makes medications out of plasma to treat chronic conditions. They operate a network of plasma donation centers all across the country. In Utah, the centers ...
Grifols, a Spanish producer of plasma protein therapies, has agreed to acquire U.S.-based Talecris for about $3.4 billion. Talecris, a former Bayer business that also develops therapies from blood ...
Grifols Biomat Plasma Center in Lewiston is scheduled to close May 21. The facility at 239 Main. St. pays people for plasma donations that are processed and used in the medical and biomedical industry ...
Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives. Since our founding in 1909, our ever-growing mastery of plasma, diagnostics and life sciences, backed by our ethical leadership and industry-leading quality ...
Grifols is also a leader in transfusion medicine, helping ensure the safety of the world’s blood supply. In addition, we provide biological materials, including plasma, for life-science research and further manufacturing, and the company has a comprehensive portfolio of tools, information and services that enable hospitals to efficiently ...